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Lamellar Bodies: The Key to
Cutaneous Barrier Function
Kenneth R. Feingold1,2
The two primary barrier functions of skin (permeability and microbial barriers) are
provided by lipids and proteins delivered to the extracellular spaces of the stratum
corneum by the secretion of lamellar bodies. Owing to their importance in this
process, the mechanisms of and the factors regulating lamellar body formation
must be better understood. Tarutani et al. (2012) provide data furthering the
concept of the importance of the Golgi network in lamellar body formation and
the necessity of acidification of the Golgi for normal function.
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It has been recognized for many years that
the cutaneous permeability barrier is
abnormal in patients with atopic dermatitis
and psoriasis, but this was consi-
dered a secondary defect owing to under-
lying immunological abnormalities and/or
inflammation. However, recent studies
have demonstrated that genetic abnormal-
ities in filaggrin lead to defects in cuta-
neous permeability barrier function and
predispose to the development of atopic
dermatitis (Irvine et al., 2011). These
studies have rekindled interest in the
abnormal cutaneous barrier as a primary
defect (Irvine et al., 2011). In addition,
genetic studies have also suggested that
the pathogenesis of psoriasis may similarly
involve abnormalities in cutaneous barrier
function (Capon et al., 2012). Thus, cuta-
neous barrier function has left the back-
waters of dermatology research to become
an area of increasing interest and study.
Although the skin has many barrier
properties, the two most important are
creating a barrier against the movement
of water and electrolytes (permeability
barrier), and creating a barrier against
the entry of microorganisms (antimicro-
bial barrier) (Elias and Choi, 2005). Both
of these barriers are localized primarily
to the stratum corneum layer of the
epidermis (Elias and Choi, 2005). The
cutaneous permeability barrier is media-
ted by extracellular lipids, cholesterol,
free fatty acids, and ceramides, which
form extracellular lipid–enriched lamellar
membranes between the corneocytes
that block the movement of water and
electrolytes (Feingold, 2007). The anti-
microbial barrier is mediated by both
lipids, particularly free fatty acids, and
antimicrobial peptides, such as the beta-
defensins and cathelicidins, which also
are localized to the extracellular spaces
of the stratum corneum (Elias and Choi,
2005; Feingold, 2007). Of particular note,
both the lipids that form the permeability
barrier and the antimicrobial peptides
are delivered to the extracellular spaces
of the stratum corneum by the secretion
of lamellar bodies (LBs; Elias and Choi,
2005; Feingold, 2007).
LBs are ovoid secretory organelles that
are first observed in the upper stratum
spinosum layer of the epidermis, with
increasing numbers found in the stratum
granulosum layer (Feingold, 2007). LBs
contain phospholipids, glucosylcera-
mides, sphingomyelin, and cholesterol
(Feingold, 2007). In addition, numerous
enzymes, including lipid hydrolases such
as b glucocerebrosidase, acidic sphingo-
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and neutral lipases, and proteases such
as chemotryptic enzymes (kallikreins)
and cathepsins, are present in LBs
(Feingold, 2007). In addition, enzyme
inhibitors, such as the serine protease
inhibitor, elafin, are also packaged into
LBs. Moreover, antimicrobial peptides,
such as human b-defensin 2 and the
cathelicidin LL-37, are also present in
LBs (Oren et al., 2003; Braff et al.,
2005). Because of the central impor-
tance of LB in the development of a
competent permeability and antimicro-
bial barrier, information on the mecha-
nisms of LB formation and the factors
that regulate the rate of formation are
needed.
Previous studies by our group have
shown that the incorporation of the lipid
constituents of LBs and the enzymes in
LBs occur coordinately and in parallel
(Rassner et al., 1999). After acute perme-
ability barrier disruption, LBs are rapidly
secreted by the stratum granulosum cells
and new LBs quickly form (Rassner
et al., 1999; Feingold, 2007). The appear-
ance of lipids and enzymes in these new
LB occurs simultaneously (Rassner et al.,
1999). Inhibiting lipid synthesis prevents
the delivery of lipids to LBs and also
prevents the incorporation of enzymes
into the LBs (Rassner et al., 1999).
Providing exogenous lipids restores the
delivery of lipids to LBs and also leads to
the incorporation of enzymes into LBs,
indicating that lipids have a key role in
facilitating the incorporation of the
enzymes into LBs (Rassner et al., 1999).
The expression of antimicrobial pep-
tides in the epidermis is also co-regulated
with permeability barrier function (Aberg
et al., 2008). Disruption of the perme-
ability barrier stimulates antimicrobial
peptide production (Aberg et al., 2008).
Moreover, in CRAMP / mice, the
synthesis of LBs following acute barrier
disruption is abnormal, leading to abnor-
malities in permeability barrier homeo-
stasis (Aberg et al., 2008). The density
of LBs in stratum granulosum cells is
normal, but the internal lamellar cargo
of the LBs is often sparse in CRAMP /
mice (Aberg et al., 2008). This suggests
that CRAMP has an important role in the
incorporation and/or organization of lipids
into LBs. Despite the paucity of lamellar
contents in CRAMP / mice, other
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proteins (e.g., the hydrolytic enzyme, acid
lipase) are packaged in LBs normally,
indicating that the incorporation of these
enzymes into LBs is not dependent on
CRAMP (Aberg et al., 2008). Interestingly,
in this model, as compared with inhibiting
lipid synthesis, the absence of lipid incor-
poration into LBs does not prevent the
packaging of enzymes into LBs, suggest-
ing that the formation of LBs may be a
complex multistep process (Aberg et al.,
2008). Whether lipids also have a key role
in facilitating the incorporation of anti-
microbial peptides into LBs has not yet
been determined.
The pathways that mediate the entry of
lipids into LBs have not been fully eluci-
dated. However, studies have shown
an important role for ABCA12 (Akiyama,
2011). ABCA12 is a member of the
ABCA subfamily of transporters, which
are involved in the transport of a variety
of lipids. Loss-of-function mutations in
ABCA12 have been shown to cause
harlequin ichthyosis, and milder mis-
sense mutations cause a severe lamellar
ichthyosis phenotype (Akiyama, 2011).
ABCA12 mutations lead to a decrease
in LB contents, a decrease in lamellar
membranes in the extracellular spaces of
the stratum corneum, and loss-of-perme-
ability barrier function, which in harlequin
ichthyosis can result in neonatal lethality
(Akiyama, 2011). Biochemically, the
absence of ABCA12 is characterized by
the accumulation of glucosylceramides
with a reduction in ceramides (Akiyama,
2011). These studies demonstrate a critical
role for ABCA12 in mediating the transport
of glucosylceramides into LBs and the
subsequent formation of mature LBs and
normal barrier function. How cholesterol
and phospholipids are transported into LBs
remains to be elucidated. ABCG1, another
member of the ATP-binding cassette super-
family, facilitates the transport of choles-
terol across the plasma membrane to HDL
particles. Our laboratory has observed
that ABCG1-null mice display abnormal
LB contents and secretion, leading to
impaired lamellar bilayer formation, sug-
gesting a potential role for ABCG1 in LB
formation (Jiang et al., 2010).
Morphological observations have
demonstrated that nascent LBs appear
to bud off the cisternae of the trans-Golgi
network, a process that accelerates after
acute barrier disruption when LB forma-
tion is accelerated (Elias et al., 1998). In
support of an important role of the Golgi,
brefeldin A, which inhibits organello-
genesis via the Golgi, blocks the form-
ation of LB (Feingold, 2007). In this issue,
Tarutani et al. (2012) provide additional
data demonstrating the importance of
the Golgi in the formation of LBs. This
group recently identified a novel anion
channel, Golgi pH Regulator (GPHR),
which is critical for Golgi acidification.
In the current article, they used a Cre-
loxP system to disrupt the expression of
GPHR, specifically in the skin. Although
a number of cutaneous abnormalities
were noted, of particular interest was
a decrease in the expression of several
lamellar body markers, including TGN46,
KLK7, and sphingomyelinase. More-
over, electron microscopy revealed that
the normal internal membrane structure
of the lamellar bodies was markedly redu-
ced, with some empty lamellar bodies
visible. As expected, given the abnormal
lamellar body appearance, the resultant
bilayer lamellar structures in the extra-
cellular spaces of the stratum corneum
were decreased in number and abnormal
in appearance. Moreover, transepidermal
water loss was increased in mice defi-
cient in GPHR, indicating an abnormal
permeability barrier. These observations
provide further evidence indicating that
LBs are derived from the Golgi appa-
ratus, and that acidification of the Golgi
is required for this process to proceed
normally.
Although this study further advances
our understanding of LB formation, many
questions remain. After acute barrier dis-
ruption, there is a marked acceleration
in LB formation. What are the signaling
pathways that lead to this increase? Is the
rate of LB formation linked with the rate
of LB secretion, and if so, what signaling
pathways link these processes? Although
ABCA12 is required for the transport of
glucosylceramides into LBs, how are the
other lipid constituents of LBs transported
into LBs? What are the pathways by
which enzymes and antimicrobial pep-
tides are incorporated into LBs? How is
the incorporation of these various compo-
nents coordinated? Is the incorporation
of the various components sequential
or simultaneous, and is the incorporation
of certain components dependent on
other components? Given the central role
of LBs in the formation of both the
permeability and antimicrobial barrier,
answering these and other questions
may allow us to manipulate the formation
of LBs and improve barrier function.
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Melanocortin 1 Receptor Function:
Shifting Gears from Determining Skin
and Nevus Phenotype to Fetal Growth
Nelleke A. Gruis1 and Remco van Doorn1
Variants in the MC1R gene influence skin pigmentation and thereby modulate
risk of melanoma and basal and squamous cell carcinoma. In this issue, Kinsler
et al. report an association between the MC1R genotype and the development
of congenital melanocytic nevi. Further, higher birth weight was observed in
carriers of MC1R variants, suggesting a role for the melanocortin network in
fetal growth.
Journal of Investigative Dermatology (2012) 132, 1953–1955. doi:10.1038/jid.2012.216
Melanocortin 1 receptor functioning and
genetic variants
The human MC1R gene, located on
chromosome 16q24.3, is highly poly-
morphic. The gene encodes for a G
protein–coupled melanocortin 1 receptor
that is expressed in melanocytes and other
cell types that reside in the skin, including
keratinocytes and fibroblasts, as well as
cells of the immune system.
The major agonists of MC1R are clea-
vage products of proopiomelanocortin,
and they include the melanocyte-stimu-
lating hormones (MSHs) and adrenocor-
ticotrophin. In particular, MC1R has high
affinity for a-MSH, which acts in an
autocrine and paracrine manner.
Activation of MC1R by a-MSH leads
to an increase of cAMP, ultimately
leading to complete activation of the
promoter of the microphthalmia tran-
scription factor (MITF) gene. MITF has a
key role in the control of melanogenesis,
leading to increased transcription of
a range of genes including TYR and
TYRP1, which are involved in the con-
trol of the relative and absolute amounts
of eumelanin and pheomelanin pigment
in the skin. The MITF transcription factor
has many other transcriptional targets,
including BCL2, MET, and HIF1A (Cheli
et al., 2010). Robbins et al. (1993)
first described the association of MC1R
variants and receptor functionality in
modulating the fur color of mice. Soon
thereafter, studies on the functionality
of MC1R variants were carried out in
humans. Population studies revealed
that several MC1R variants are associ-
ated with red hair and fair skin, desig-
nated as red hair color (RHC) and fair
skin variants. Interestingly, the variant
alleles differ in their penetrance concern-
ing the RHC phenotype (Sturm, 2002).
The common variants R151C, R160W,
and D294H and the rarely occurring
variants D84E and R142H are strongly
associated with the red hair phenotype
in the Caucasian population, with odds
ratios of 50- to 120-fold (referred to
as (strong) R variants). The weak RHC
alleles V60L, V92M, and R163Q have
odds ratios for red hair between 2 and 6
and are therefore considered to be
(weak) r variants. Soon after the corre-
lations were observed between MC1R
variants and the RHC phenotype, asso-
ciations were observed between these
variants and other skin-related pheno-
types, such a risk of developing mela-
noma and non-melanoma skin cancer,
as well as freckles (Sturm, 2002). Interest-
ingly, associated odds ratios increased
when more RHC variants were present
in the genotype, with homozygous R
variants conferring the highest risk.
Despite the fact that more than 100
variants in the MC1R gene have been
identified to date, the consequences of
these variants on the physiological func-
tion of MC1R have been defined only
partially (Dessinioti et al., 2011). RHC
variants R151C, R160W, and D294H
have been defined as strong RHC (R)
variants based not only on their signifi-
cant associations with specific pheno-
typic features, such as red hair, fair
skin, and freckling, but also on their
diminished receptor function, reduced
response to a-MSH, and reduced func-
tional coupling of MC1R to adenylate
cyclase in vitro. The functional relevance
of the weaker (low penetrant) RHC (r)
variants, such as V60L, V92M, and
R163Q, is still a matter of debate, with
some reports pointing to a minor signal-
ing impairment, and others showing
a behavior similar to that of wild-type
MC1R (Dessinioti et al., 2011). One
report suggested that the V92M substitu-
tion reduces the binding affinity of MC1R
for a-MSH, whereas another found no
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